300347.SZ

Hangzhou Tigermed Consulting Co., Ltd. 300347.SZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode 300347.SZ 002223.SZ 603087.SS 600332.SS 300759.SZ 600161.SS 603127.SS 688617.SS 300003.SZ 002821.SZ
6M 20.14 % 7.00 % 55.45 % -2.10 % 39.33 % -6.55 % 108.75 % 6.23 % 54.22 % 62.15 %
YTD -3.25 % 2.80 % 65.73 % -6.65 % 23.00 % -5.39 % 89.94 % 32.30 % 59.17 % 41.81 %
1Y -21.63 % 4.89 % 39.31 % -10.73 % 7.09 % -13.36 % 88.08 % 32.22 % 39.13 % 37.03 %
3Y -34.43 % 27.36 % 105.62 % -2.61 % -4.47 % 7.77 % -20.68 % 100.56 % -28.89 % -22.56 %
5Y -55.13 % 16.82 % -44.92 % -18.41 % -37.56 % -28.35 % -14.16 % 87.22 % -45.01 % -47.90 %
10Y 114.51 % 40.16 % 7.31 % -10.08 % 531.84 % 129.93 % 1 266.95 % 87.22 % -14.74 % 572.04 %
From the beginning 1 176.26 % 2 008.05 % 7.31 % 406.90 % 531.84 % 2 919.06 % 1 266.95 % 87.22 % 9.46 % 572.04 %

Dividend

Hangzhou Tigermed Consulting Co., Ltd.

Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.

Gan & Lee Pharmaceuticals.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Pharmaron Beijing Co., Ltd.

Beijing Tiantan Biological Products Co., Ltd.

Joinn Laboratories(China)Co.,Ltd.

APT Medical Inc.

Lepu Medical Technology (Beijing) Co., Ltd.

Asymchem Laboratories (Tianjin) Co., Ltd.